Chondrosarcoma

1,672views

Chondrosarcoma

MSK Block 2

MSK Block 2

Fibrous, cartilage, and synovial joints

Cartilage histology

Skeletal muscle histology

Bone remodeling and repair

Lordosis, kyphosis, and scoliosis

Osteomalacia and rickets

Osteoporosis medications

Ankylosing spondylitis

Gout and pseudogout: Pathology review

Reactive arthritis

Rheumatoid arthritis

Non-biologic disease modifying anti-rheumatic drugs (DMARDs)

Rheumatoid arthritis and osteoarthritis: Pathology review

Psoriatic arthritis

Septic arthritis

Seronegative and septic arthritis: Pathology review

Muscular dystrophy

Inclusion body myopathy

Muscular dystrophies and mitochondrial myopathies: Pathology review

Dermatomyositis

Erb-Duchenne palsy

Compartment syndrome

Developmental dysplasia of the hip

Pediatric musculoskeletal disorders: Pathology review

Systemic lupus erythematosus

Systemic lupus erythematosus (SLE): Pathology review

Bone tumors: Pathology review

Osteogenesis imperfecta

Calcium pyrophosphate deposition disease (pseudogout)

Juvenile idiopathic arthritis

Dislocated shoulder

Growth hormone and somatostatin

Growth hormone deficiency

Constitutional growth delay

Thyroid hormones

Hashimoto thyroiditis

Glucocorticoids

Staphylococcus aureus

Key Takeaways

Chondrosarcoma is a malignant tumor that originates in the mesenchymal cells of (cells that produce) cartilage. Chondrosarcoma most commonly affects the medullary cavity of the pelvis, proximal humerus, and femur. Symptoms of chondrosarcoma include pain, swelling, weight loss, and pathological fractures. Chondrosarcoma is diagnosed through physical examination, imaging tests (such as X-rays, MRI scans, or CT scans), and tissue biopsy.